$AMED is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 2 active Congressional signals mentioning $AMED, including 2 bills. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
$AMED is currently facing 2 active congressional signals tracked by HillSignal. With 0 bullish, 2 neutral, and 0 bearish signals, covering 2 sectors. Key sectors affected include Healthcare and Consumer. Recent major catalysts include Hospice CARE Act of 2026 and Domestic Workers Bill of Rights Act. Below is the complete tracker of government activity affecting $AMED’s market performance.
HR7966 (Hospice CARE Act of 2026) proposes a 5-year nationwide moratorium on new Medicare hospice enrollment, but is in early legislative stages—referred to committee with only 2 cosponsors. No explicit funding, no near-term market impact. No public companies directly affected at this stage.
S.3396 is an early-stage bill referred to committee with no direct market impact on any publicly traded company. It establishes labor standards and a board for household domestic workers but has no funding or provisions affecting public corporations. Retail investors should ignore this legislation.